An immune signature to predict the prognosis of <i>ATRX</i>-wildtype glioma patients and guide immune checkpoint blockade therapy

Wenpeng Cao; Ping Sun; Shipeng Luo; Zhirui Zeng; Chaolun Xiao; Wenfeng Yu; Shan Lei

doi:doi:10.18632/aging.205088

← Back

Research Paper Volume 15, Issue 19 pp 10453—10472

An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy

Figure 8. Construction of the nomogram. (A) Construction of a nomogram using age, sex, grade and risk score. (B) Nomogram in glioma patients with one-, three- and five-year survival.